Literature DB >> 8682485

A long-term investigation of transcatheter splenic arterial embolization for hypersplenism.

K Sakata1, K Hirai, K Tanikawa.   

Abstract

BACKGROUND/AIMS: This study investigated longterm changes in the parameters of blood and liver function tests following TSAE. PATIENTS AND MATERIALS: Twenty-five patients received transcatheter splenic arterial embolization (TSAE) as a treatment for hypersplenism, and their post- TSAE conditions were monitored for over a year. We evaluated changes in blood and liver function tests, and examined changes of platelet associated immunoglobulin G (PA-IgG), liver and spleen volumes and hemodynamics in order to consider the mechanism of liver function improvement following TSAE.
RESULTS: In blood tests, platelet and WBC counts significantly increased one year after TSAE and this increased level continued up to the fifth year. In liver function tests, levels of serum total protein, albumin, total cholesterol, and results of the hepaplastin test significantly improved after the one year, and these levels remained even over one year.
CONCLUSIONS: Results of this study indicated involvements of decreased platelet pool in the spleen and probable immunological mechanisms in association with PA-IgG in platelet count increase. Indocyanine green clearance (15') were improved in 5 of 8 patients (62.5%) after TSAE. These points may indicate an involvement of hemodynamic changes in the improvement of liver function parameters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682485

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

2.  Complications of partial splenic embolization in cirrhotic patients.

Authors:  Takahisa Sakai; Katsuya Shiraki; Hidekazu Inoue; Kazushi Sugimoto; Shigeru Ohmori; Kazumoto Murata; Koujiro Takase; Takeshi Nakano
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

3.  A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.

Authors:  Hiroki Tahara; Hitoshi Takagi; Ken Sato; Yasushi Shimada; Hiroki Tojima; Tomoyuki Hirokawa; Tatsuya Ohyama; Katsuhiko Horiuchi; Atsushi Naganuma; Hirotaka Arai; Satoru Kakizaki; Masatomo Mori
Journal:  J Gastroenterol       Date:  2011-05-19       Impact factor: 7.527

4.  Partial splenic embolization: long-term outcome.

Authors:  Birger Pålsson; Magnus Hallén; Annika Mandahl Forsberg; Anders Alwmark
Journal:  Langenbecks Arch Surg       Date:  2003-01-15       Impact factor: 3.445

5.  Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.

Authors:  Jin-Hua Huang; Fei Gao; Yang-Kui Gu; Wen-Quan Li; Lian-Wei Lu
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

6.  Splenic artery embolization as an adjunctive procedure for portal hypertension.

Authors:  Mitchell Smith; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

7.  Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes.

Authors:  Mohamed M A Zaitoun; Mohammad Abd Alkhalik Basha; Saeed Bakry Elsayed; Dalia Salah El Deen; Nahla A Zaitoun; Husain Alturkistani; Alaa A Farag; Hassan Abdelsalam; Hossam A El-Kenawy; Nader E M Mahmoud; Nader Ali Alayouty; Ibrahim M Eladl; Shahenda Shahin; Mohamed-Karji Almarzooqi; Ali M Hendi; Ahmad El-Morsy; Ali Hassan Elmokadem
Journal:  Insights Imaging       Date:  2021-06-26

8.  Partial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration.

Authors:  Adrianne Netterville; Ronald Lands
Journal:  Case Rep Hematol       Date:  2012-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.